Pierrel Research is proud to announce the recent publication in 'Cerebrovascular Diseases' of the original paper entitled: “Atherothrombotic Burden and Medium-Term Prognosis in Patients with Acute Ischemic Stroke: Findings of the SIRIO Study” (Cerebrovasc Dis 2012; 33:341-347).
eDiary data collection via an App on smartphone – this is a new Clinical Trial Solution developed by Pierrel Research.
The Pierrel Research department Clinical Trial Technology (CTT) dedicates a great deal of time and innovative thinking into each trial project (clinical & non-clinical)
Bachem Group (SIX: BANB) recorded sales of 145.8 million CHF in the challenging 2011 financial year (previous year 152.9 million CHF). Calculated at constant exchange rates (CER) sales amounted to 161.4 million CHF, which corresponds to 5.5% sales growth in local currency.
A new look and a user‐friendly structure: Haupt Pharma has redesigned its website. At Haupt Pharma visitors to the website now receive a wealth of information about one of the leading and largest contract manufacturers in Europe. The internet site in German and English also supports the international presence of Haupt Pharma.
Suzhou Pharma Services an affiliate of Amerigen Pharmaceuticals, a new contract development and manufacturing organization specializing in solid oral dosage forms, is proud to announce our new corporate headquarters in Lyndhurst, New Jersey and the company’s primary manufacturing facility located in Suzhou, China.
Visit Peak Scientific at the 29th ISC at the Assembly Hall of the Nicolaus University Campus in Torun, Poland from the 9th to the 13th of September 2012
Visit Peak Scientific at the HUPO 11th annual world congress in the Hvnes Convention Centre from the 9th to the 13th of September 2012 in Boston, Massachusetts.
Come visit Peak Scientific at the Kyoto International Conference centre for IMSC2012 from the 15th to the 21st of September in Kyoto, Japan.
In response to increased customer orders and the signing of long-term contracts, SHL has hired more than 600 new employees over a 14 month period of time. SHL, the world's largest privately owned designer, developer and manufacturer of drug delivery devices, now has over 2,000 employees worldwide with the majority of new staff located at the manufacturing facilities in Taiwan.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.